Xyloglucan from tropaeolum majus seeds induces cellular differentiation of human keratinocytes by inhibition of EGFR phosphorylation and decreased activity of transcription factor CREB

Zacharski D., Brandt S., Esch S., König S., Mormann M., Ulrich-Merzenich G., Hensel A.

Forschungsartikel (Zeitschrift) | Peer reviewed

Zusammenfassung

Xyloglucan XG (molecular weight 462 kDa, 1,4-/1,4,6-(pGlc) linked backbone, side chains of 1-pXyl, 1,2-pXyl, 1-p-Gal) was isolated from the seeds of Tropaeolum majus. XG (100 μg/mL) induced terminal cellular differentiation of human keratinocytes, as demonstrated by immunofluorescence staining and Western blot using cytokeratin 10 and involucrin as marker proteins. Differentiation was also induced by XG-derived oligosaccharides (degree of polymerization 7-9). Quantitative real-time polymerase chain reaction (qPCR) revealed the induction of gene expression of typical differentiation markers (cytokeratin, filaggrin, involucrin, loricrin, transglutaminase) in a time-dependent manner. Whole human genome microarray indicated that most of upregulated genes were related to differentiation processes. Microarray findings on selected genes were subsequently confirmed by qPCR. For identification of the molecular target of xyloglucan PAGE of keratinocyte membrane preparations was performed, followed by blotting with fluorescein isothiocyanate-labeled XG. XG interacting proteins were characterized by MS. Peptide fragments of epidermal growth factor receptor (EGFR) and integrin β4 were identified. Subsequent phospho-kinase array indicated that phosphorylation of EGFR and transcription factor cAMP response element-binding protein (CREB) was decreased in the XG-treated cells. Thus, the XG-induced differentiation of keratinocytes is proposed to be mediated by the inhibition of the phosphorylation of EGFR, leading to a dimished CREB activation, which is essential for the activation of cellular differentiation.

Details zur Publikation

FachzeitschriftBiomacromolecules
Jahrgang / Bandnr. / Volume16
Ausgabe / Heftnr. / Issue7
Seitenbereich2157-2167
StatusVeröffentlicht
Veröffentlichungsjahr2015
Sprache, in der die Publikation verfasst istEnglisch
DOI10.1021/acs.biomac.5b00553
Link zum Volltexthttp://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84937060950&origin=inward

Autor*innen der Universität Münster

Brandt, Simone
Professur für Pharmazeutische Biologie (Prof. Hensel)
König, Simone
Interdisziplinäres Zentrum für Klinische Forschung (IZKF) in der Med. Fakultät (IZKF)
Mormann, Michael
Institut für Hygiene